Back

Case-Based Guidance on Tailoring Treatment Selection for Menopause-Related VMS

In this case-based enduring activity, clinicians are provided best practices on delivering personalized care with integration of NK receptor antagonists to patients with moderate-to-severe VMS. As a result of this educational activity, learners will be better able to: 1. Integrate communication about menopause and VMS into routine patient encounters; 2. Review treatment options for moderate-to-severe VMS, including NK receptor antagonists, with patients using a shared decision-making approach; and, 3. Formulate strategies for optimally monitoring patients who are receiving NK receptor antagonists for menopause-related VMS. Learners have access to downloadable materials to extend their practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Microlearning
  • includes Case-based learning
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Sep 3, 2026
  • Last day to claim credit
    Sep 3, 2027 11 months left